Belatacept in Pancreas Transplantation: Promising Insights From a Cohort Series.
作者信息
Masset Christophe, Garandeau Claire, Ville Simon, Giral Magali, Houzet Aurélie, Branchereau Julien, Chelghaf Ismaël, Mesnard Benoit, Blancho Gilles, Dantal Jacques, Cantarovich Diego
机构信息
Institut de Transplantation-Urologie-Néphrologie (ITUN), Nantes University Hospital, Nantes, France.
Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, Unité Mixte de Recherche (UMR), Nantes, France.
出版信息
Transpl Int. 2024 Apr 16;37:12778. doi: 10.3389/ti.2024.12778. eCollection 2024.
Abstract
摘要
相似文献
1
Belatacept in Pancreas Transplantation: Promising Insights From a Cohort Series.
Transpl Int. 2024 Apr 16;37:12778. doi: 10.3389/ti.2024.12778. eCollection 2024.
2
Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept.
BMC Nephrol. 2020 Aug 20;21(1):354. doi: 10.1186/s12882-020-01992-6.
3
Abatacept as rescue immunosuppression after calcineurin inhibitor treatment failure in renal transplantation.
Am J Transplant. 2019 Aug;19(8):2342-2349. doi: 10.1111/ajt.15319. Epub 2019 Mar 12.
4
Belatacept Rescue Therapy in the Early Period After Simultaneous Kidney-Pancreas Transplantation.
Transpl Int. 2024 Apr 11;37:12628. doi: 10.3389/ti.2024.12628. eCollection 2024.
5
Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function.
Am J Transplant. 2017 Nov;17(11):2922-2936. doi: 10.1111/ajt.14353. Epub 2017 Jul 3.
6
Early conversion to belatacept after renal transplantation.
Clin Transplant. 2017 May;31(5). doi: 10.1111/ctr.12951. Epub 2017 Apr 19.
7
Belatacept rescue for delayed kidney allograft function in a patient with previous combined heart-liver transplant.
Am J Transplant. 2018 Oct;18(10):2613-2614. doi: 10.1111/ajt.15003. Epub 2018 Aug 3.
8
Effect of an Early Switch to Belatacept Among Calcineurin Inhibitor-Intolerant Graft Recipients of Kidneys From Extended-Criteria Donors.
Am J Transplant. 2016 Jul;16(7):2181-6. doi: 10.1111/ajt.13698. Epub 2016 Mar 2.
9
Long-Term Outcomes after Conversion to a Belatacept-Based Immunosuppression in Kidney Transplant Recipients.
Clin J Am Soc Nephrol. 2024 May 1;19(5):628-637. doi: 10.2215/CJN.0000000000000411. Epub 2024 Feb 22.
10
Belatacept Compared With Tacrolimus for Kidney Transplantation: A Propensity Score Matched Cohort Study.
Transplantation. 2017 Oct;101(10):2582-2589. doi: 10.1097/TP.0000000000001589.
引用本文的文献
1
Thrombotic Microangiopathy After Kidney Pancreas Transplant Managed With Eculizumab and a Calcineurin Inhibitor-free Basiliximab/Belatacept Maintenance Regimen: Between a Rock and a Hard Place.
Transplant Direct. 2025 Jun 12;11(7):e1825. doi: 10.1097/TXD.0000000000001825. eCollection 2025 Jul.
2
The Use of Long-Term Monthly Basiliximab Infusions as Rescue Maintenance Immunosuppression in Pancreas Transplant Recipients.
Clin Transplant. 2024 Dec;38(12):e70050. doi: 10.1111/ctr.70050.
本文引用的文献
1
A Multi-Modal Approach to Islet and Pancreas Transplantation With Calcineurin-Sparing Immunosuppression Maintains Long-Term Insulin Independence in Patients With Type I Diabetes.
Transpl Int. 2023 Jun 8;36:11367. doi: 10.3389/ti.2023.11367. eCollection 2023.
2
Prevention of acute rejection after rescue with Belatacept by association of low-dose Tacrolimus maintenance in medically complex kidney transplant recipients with early or late graft dysfunction.
PLoS One. 2020 Oct 15;15(10):e0240335. doi: 10.1371/journal.pone.0240335. eCollection 2020.
3
Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters.
Transplant Direct. 2019 Dec 24;6(1):e517. doi: 10.1097/TXD.0000000000000964. eCollection 2020 Jan.
4
Challenges of calcineurin inhibitor withdrawal following combined pancreas and kidney transplantation: Results of a prospective, randomized clinical trial.
Am J Transplant. 2020 Jun;20(6):1668-1678. doi: 10.1111/ajt.15817. Epub 2020 Mar 8.
5
Tacrolimus- versus sirolimus-based immunosuppression after simultaneous pancreas and kidney transplantation: 5-year results of a randomized trial.
Am J Transplant. 2020 Jun;20(6):1679-1690. doi: 10.1111/ajt.15809. Epub 2020 Feb 28.
Zotero 插件